Selecting Treatment for Late-Stage SCLCByAfshin Dowlati, MDMarch 25th 2022Afshin Dowlati, MD, discusses treatment decision-making for patients with late-stage small cell lung cancer.
Frontline Targeted Options for EGFR-Mutated NSCLCByAfshin Dowlati, MDMarch 21st 2022Afshin Dowlati, MD, discusses the targeted therapies available for patients with EGFR-mutated late-stage non–small cell lung cancer.